Catalyst Wire Dossier Catalyst Wire Dossier

Fedratinib (Inrebic)

fedratinib · Sanofi
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Fedratinib (Inrebic), covering 2026-04-08 to 2026-04-08. Get the full timeline:

Most recent: Clinical Trial Update: Fedratinib in Combination With Nivolumab [Phase 2]

See pricing